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Physical activity is being increasingly recognised as a factor that modulates co-
morbidities and adverse outcome in patients with COPD.1 Attention to physical 
inactivity is therefore of the utmost importance, particularly in patients who are not yet 
severely impaired by their lung function and are managed in primary care. Enhancing 
physical activity in these patients may have potential spin-offs, with important 
improvements in the burden of COPD co-morbidities. Many of the ‘typical COPD co-
morbidities’ are indeed associated with lack of physical activity.  
 
In this issue of the PCRJ, Fastenau and co-workers report low physical activity levels 
in a group of patients followed-up in primary care.2 In these patients with GOLD stage 
I and II disease, 33% of patients had a step count of around 5000 or less, which is 
conventionally seen as one of the benchmarks for ‘sedentarism’3. This study is yet 
another call for action to healthcare providers managing these patients – patients 
who have, at first sight, ‘mild to moderate’ COPD. Measuring physical activity is no 
luxury reserved for lifestyle clubs. Physical activity should be considered a ‘vital 
sign’,4 and the study by Fastenau et al. shows this clearly.  
 
The authors also conclude that there is a poor relation between exercise capacity – 
as assessed by the six minute walk test (6MWT) in this study – and physical activity.2 
This poor relation can perhaps be explained to some extent by methodological 
factors in their study: possible selection bias with selection based on impaired 
exercise tolerance and low physical activity; for the 6MWT, the corridor not being of 
standard length and the possibility that there was no practice walking test; and, in 
terms of the activity monitor data and analysis, seasonal variation was not taken into 
account for the correlation analyses and there was no report of compliance with 
monitor use. 
 
However, the poor relation between exercise capacity and physical activity behavior 
shown in this study2 should not come as a surprise. Leidy et al. speculated years ago 
that physical activity and functional capacity were two different concepts.5 When 
functional capacity is larger (i.e. there is better 6MWT performance) patients have 
more choice regarding engagement in physical activity. Physical activity is indeed a 
complex endpoint, influenced by several factors. The factors best understood 
intuitively are personal factors (including genetic), exercise-related factors, and 
psychological factors. Other factors influencing patients’ choice whether or not to 
engage in physical activity are linked to interpersonal aspects (social support, as an 
example), environmental factors (climate, social environment and architectural) and 
policy (e.g. public transport, incentives for physical activity).6  
 
So, in comparison with other studies performed in ‘milder’ (or primary care) COPD 
patients,7-9 the present study2 confirms for primary care practitioners that physical 
activity is low in many patients with COPD. Low physical activity levels are the best 
guarantee that patients will develop co-morbidity (on top of their many pack-years of 
smoking). What should one do next?  
 
Firstly, assessment of physical activity is of the utmost importance. This is also what 
Fastenau and co-workers conclude.2 Questionnaires may help to identify severely 
inactive patients,10 but they largely fail to provide a correct reflection of physical 
activity across the whole spectrum. Physical activity monitors have become more 
readily available, and in the European IMI-JU PROactive project 
(www.PROactiveCOPD) some of these monitors are identified as being valid tools for 
the assessment of physical activity in patients with COPD.11 The use of activity 
monitors in primary care has been proposed and validated by others.12 In the future, 
the use of smart phones containing accelerometers may help in profiling patients at 
little cost and, importantly, with low time investment.  
 
Secondly, primary care physicians and healthcare providers in general should be 
aware of the risks of physical inactivity. An attributed mortality of around 10% cannot 
be underestimated.13 All healthcare providers should be aware that inactive patients 
with COPD will eventually develop co-morbidities which will complicate significantly 
their disease management.  
 
Lastly, enhancing physical activity is a challenge, and there is no ‘miracle solution’. 
Simple interventions such as the use of pedometers with agreed physical activity 
targets may help patients to enhance physical activity levels. Increasingly, we will see 
health technology applications appear which promote physical activity.14 Pilot studies 
have been undertaken with these techniques in patients with mild COPD. Concerted 
efforts between healthcare providers, policy makers and social support initiatives are 
likely to be successful in the long term.15 One example is an initiative in Catalunia 
where, in collaboration with the city engineers, walking circuits were designed in the 
city to fit the needs of patients with COPD.16 The use of these walking trails did 
increase physical activity in patients who completed a pulmonary rehabilitation 
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programme. Such community-based efforts should be fostered, since they may 
benefit not just patients with COPD but also patients with obesity or those at risk of 
developing Type II diabetes. Guidelines should exist at a local level on when and 
how to refer patients with COPD for physical activity-enhancing interventions. Such 
guidelines do exist in the Netherlands,17 where the study by Fastenau et al. took 
place. In the absence of guidelines, the general guidelines from the Center for 
Disease Control in the USA4 could be used as a basis, and local policy makers 
should attempt to provide incentives (financial and other) to promote health-
enhancing behavior, rather than focussing on treating the consequences of physical 
inactivity. Partial reimbursement of health club fees is a good example, an initiative 
which has been studied in patients with diabetes.18  
 
In summary, Fastenau et al. should be complimented on their study which recruited 
patients from 20 general practices in the Netherlands. They clearly highlight the low 
and largely unpredictable physical activity levels in patients with COPD selected in 
primary care. Screening for physical activity in primary care should be considered, 
and action should be undertaken when patients are labeled as inactive. Despite the 
enthusiasm, healthcare providers should be aware that changing physical activity 
entails behavior change, and inherent resistance to change may negatively impact on 
the success of interventions. Nevertheless, when successful the long-term health 
benefits for patients surely justify the efforts…   
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